Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LEGN - Week In Review: Everest Announces 2 In-Licensings With Total Value Of $1 Billion

LEGN - Week In Review: Everest Announces 2 In-Licensings With Total Value Of $1 Billion

Legend Biotech Corporation
  • Shanghai Everest Medicines in-licensed a BTK inhibitor for renal diseases from Suzhou Sinovent and SinoMab Bio in a $561 million deal.
  • The company also announced a $500 million two-part deal with Providence Therapeutics of Calvery, Canada for mRNA products.
  • Cue Health, a San Diego company with a home testing kit for COVID-19, filed for a $180 million IPO on Nasdaq that values the company at $2 billion.
  • Nanjing Legend Biotech has started a US Phase 1 trial of its autologous CD4 CAR-T therapy for lymphoma.

For further details see:

Week In Review: Everest Announces 2 In-Licensings With Total Value Of $1 Billion
Stock Information
Company Name: Legend Biotech Corporation
Stock Symbol: LEGN
Market: NASDAQ
Website: legendbiotech.com
Menu
LEGN LEGN Quote LEGN Short LEGN News LEGN Articles LEGN Message Board
Get LEGN Alerts

News, Short Squeeze, Breakout and More Instantly...